Amgen Restructures Amid Anemic Aranesp Sales
Biotech will eliminate up to 2,600 jobs, prioritize R&D spend to achieve $1 billion to $1.3 billion in pre-tax savings.
Biotech will eliminate up to 2,600 jobs, prioritize R&D spend to achieve $1 billion to $1.3 billion in pre-tax savings.